These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 31471582)

  • 21. Induction of genetic instability by gain-of-function p53 cancer mutants.
    Xu Y
    Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription regulation by mutant p53.
    Weisz L; Oren M; Rotter V
    Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in p53 research: an interdisciplinary perspective.
    Olivier M; Petitjean A; Marcel V; Pétré A; Mounawar M; Plymoth A; de Fromentel CC; Hainaut P
    Cancer Gene Ther; 2009 Jan; 16(1):1-12. PubMed ID: 18802452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Friend or Foe: MicroRNAs in the p53 network.
    Luo Z; Cui R; Tili E; Croce C
    Cancer Lett; 2018 Apr; 419():96-102. PubMed ID: 29330109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disrupting TP53 in mouse models of human cancers.
    Parant JM; Lozano G
    Hum Mutat; 2003 Mar; 21(3):321-6. PubMed ID: 12619119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
    Cui Y; Guo G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of p53 protein in human tumors.
    Inoue K; Kurabayashi A; Shuin T; Ohtsuki Y; Furihata M
    Med Mol Morphol; 2012 Jun; 45(3):115-23. PubMed ID: 23001293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 and human cancers.
    Lane DP
    Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant p53 as a guardian of the cancer cell.
    Mantovani F; Collavin L; Del Sal G
    Cell Death Differ; 2019 Jan; 26(2):199-212. PubMed ID: 30538286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 mutations in cancer.
    Muller PA; Vousden KH
    Nat Cell Biol; 2013 Jan; 15(1):2-8. PubMed ID: 23263379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant p53 partners in crime.
    Kim MP; Lozano G
    Cell Death Differ; 2018 Jan; 25(1):161-168. PubMed ID: 29099488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 mutation, mitochondria and cancer.
    Kamp WM; Wang PY; Hwang PM
    Curr Opin Genet Dev; 2016 Jun; 38():16-22. PubMed ID: 27003724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [P53 protein: a new tool for the clinician?].
    Laurent-Puig P
    Gastroenterol Clin Biol; 1995 May; 19(5):463-4. PubMed ID: 7589996
    [No Abstract]   [Full Text] [Related]  

  • 35. [The cooperation between p53 and Ras in tumorigenesis].
    Wei YY; Hou J; Tang WR; Luo Y
    Yi Chuan; 2012 Dec; 34(12):1513-21. PubMed ID: 23262097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant p53: an oncogenic transcription factor.
    Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
    Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
    Workman P
    Hum Exp Toxicol; 1995 Feb; 14(2):222-5. PubMed ID: 7779451
    [No Abstract]   [Full Text] [Related]  

  • 38. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in p53 research and cancer treatment.
    Suzuki K; Matsubara H
    J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 tetramerization: at the center of the dominant-negative effect of mutant p53.
    Gencel-Augusto J; Lozano G
    Genes Dev; 2020 Sep; 34(17-18):1128-1146. PubMed ID: 32873579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.